bf/NASDAQ:SGEN_icon.png

NASDAQ:SGEN

Seagen Inc.

  • Stock

USD

Last Close

228.90

13/12 21:00

Market Cap

43.15B

Beta: 0.53

Volume Today

19.39M

Avg: 1.64M

PE Ratio

−57.36

PFCF: −61.54

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothel...Show More

Earnings

Earnings per Share (Estimate*)

-2-11232015-02-102017-02-092019-02-072021-02-112023-02-15

Revenue (Estimate*)

500M1B1.50B2015-02-102017-02-092019-02-072021-02-112023-02-15

*Estimate based on analyst consensus